A share price of Opko Health Inc [OPK] is currently trading at $1.64, up 1.23%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OPK shares have gain 7.89% over the last week, with a monthly amount glided 12.33%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Opko Health Inc [NASDAQ: OPK] stock has seen the most recent analyst activity on June 29, 2023, when Barrington Research upgraded its rating to a Outperform but kept the price target unchanged to $2 for it. Previously, H.C. Wainwright started tracking the stock with Buy rating on December 15, 2022, and set its price target to $3. On January 24, 2022, downgrade downgraded it’s rating to Mkt Perform. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $7 on June 21, 2021. Piper Jaffray initiated its recommendation with a Overweight and recommended $2.50 as its price target on November 25, 2019. JP Morgan downgraded its rating to Underweight for this stock on March 02, 2018. In a note dated September 14, 2017, JP Morgan downgraded an Neutral rating on this stock.
Opko Health Inc experienced fluctuations in its stock price throughout the past year between $0.85 and $1.75. Currently, Wall Street analysts expect the stock to reach $3.5 within the next 12 months. Opko Health Inc [NASDAQ: OPK] shares were valued at $1.64 at the most recent close of the market. An investor can expect a potential return of 113.41% based on the average OPK price forecast.
Analyzing the OPK fundamentals
Trailing Twelve Months sales for Opko Health Inc [NASDAQ:OPK] were 711.40M which represents -2.78% decline. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -0.26%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.1 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5833 points at the first support level, and at 1.5267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6733, and for the 2nd resistance point, it is at 1.7067.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Opko Health Inc [NASDAQ:OPK] is 2.97. As well, the Quick Ratio is 2.69, while the Cash Ratio is 1.92. Considering the valuation of this stock, the price to sales ratio is 1.59, the price to book ratio is 0.80.
Transactions by insiders
Recent insider trading involved FROST PHILLIP MD ET AL, CEO & Chairman, that happened on Nov 14 ’24 when 100000.0 shares were purchased. CEO & Chairman, FROST PHILLIP MD ET AL completed a deal on Nov 08 ’24 to buy 0.28 million shares. Meanwhile, 10% Owner OPKO HEALTH, INC. bought 13404.0 shares on Sep 17 ’24.
